Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — April 2024

Genmab — April 2024

Planlagt Fastgjort Låst Flyttet Genmab
759 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • W Offline
    W Offline
    w
    wrote on sidst redigeret af
    #742

    jyske undrer sig også over fald ovenpå positive nyheder

    1 Reply Last reply
    0
    • L Offline
      L Offline
      lahn1
      wrote on sidst redigeret af
      #743

      Det skrev Jyske også for 3 mdr siden

      1 Reply Last reply
      0
      • R Offline
        R Offline
        Raun
        wrote on sidst redigeret af
        #744

        Hvor er det da ved at være pinligt for Jyske Bank.... - Hold nu op, hvor har de gentaget sig selv mange gange igennem de seneste måneder.... - De må have et ordentlig læs aktier de meget gerne vil af med 🙂

        1 Reply Last reply
        0
        • G Offline
          G Offline
          GeorgeBest
          wrote on sidst redigeret af
          #745

          Thanks E L. Do you know how the forecasters see the market share split between epco versus glofi/monesu? 50/50?

          1 Reply Last reply
          0
          • E Offline
            E Offline
            E_L
            wrote on sidst redigeret af
            #746

            no, i don't. would be fun indeed to look at these same analysts forecasts for that

            1 Reply Last reply
            0
            • E Offline
              E Offline
              E_L
              wrote on sidst redigeret af
              #747

              Bio-Techne Corporation (NASDAQ: TECH) today announced the appointment of Dr. Judith Klimovsky to serve as an independent director on the Company's Board of Directors https://investors.bio-techne.com/press-releases/detail/418/bio-techne-appoints-dr-judith-klimovsky-to-board-of -Bio-Techne is a leading supplier of high quality and innovative tools for Life Science Research, Therapeutic Manufacturing and Clinical Diagnostics.

              1 Reply Last reply
              0
              • E Offline
                E Offline
                E_L
                wrote on sidst redigeret af
                #748

                the new Endometrial Cancer trial with GEN1046 will not continue; due to [Enrollment challenged by availability of other treatment options] https://classic.clinicaltrials.gov/ct2/history/NCT06046274?A=10&B=11&C=merged#StudyPageTop

                1 Reply Last reply
                0
                • E Offline
                  E Offline
                  E_L
                  wrote on sidst redigeret af
                  #749

                  it seems no patients were recruited yet, so the costs should be limited

                  1 Reply Last reply
                  0
                  • E Offline
                    E Offline
                    E_L
                    wrote on sidst redigeret af
                    #750

                    New trial - Trial to Assess the Safety and Preliminary Efficacy of GEN1055 on Malignant Solid Tumors as Monotherapy and as Combination Therapy (HexaBody-OX40) https://clinicaltrials.gov/study/NCT06391775

                    1 Reply Last reply
                    0
                    • E Offline
                      E Offline
                      E_L
                      wrote on sidst redigeret af
                      #751

                      TECVAYLI available in Spain from may1 https://www.vademecum.es/noticia-240430-Disponible+en+Espa+ntilde+a+++9660+TECVAYLI+sup++reg+++sup+++teclistamab+++el+primer+anticuerpo+biespec+iacute+fico+anti++BCMA+sup++1++sup++autorizado+para+el+tratamiento+de+pacientes+triple+expuestos+con+mieloma+m+uacute+ltiple_90351

                      1 Reply Last reply
                      0
                      • L Offline
                        L Offline
                        lahn1
                        wrote on sidst redigeret af
                        #752

                        Hvorlænge skal man havde været aktionær i Gmab for at kunne kalde sig for En Tålmodig Invester ?

                        1 Reply Last reply
                        0
                        • V Offline
                          V Offline
                          Vitus
                          wrote on sidst redigeret af
                          #753

                          Godt spørgsmål, men jeg er overbevist om, at mange har mistet tålmodigheden !

                          1 Reply Last reply
                          0
                          • J Offline
                            J Offline
                            JKY_VH
                            wrote on sidst redigeret af
                            #754

                            Alt godt kommer til den der har tålmodigheden til at vente;-)

                            1 Reply Last reply
                            0
                            • P Offline
                              P Offline
                              Pensionisten
                              wrote on sidst redigeret af
                              #755

                              ADS'en har det lidt skidt lige nu - nede med 2,94%

                              1 Reply Last reply
                              0
                              • R Offline
                                R Offline
                                Raun
                                wrote on sidst redigeret af
                                #756

                                Er det korrekt at JnJ har hele 2024 til at gøre brug af sin opt in?...... Og er det kor
                                rekt at der vil komme yderligere data på CD38, her i løbet af andet kvartal?

                                1 Reply Last reply
                                0
                                • S Offline
                                  S Offline
                                  Sukkeralf
                                  wrote on sidst redigeret af
                                  #757

                                  Nej og nej - hexCD38 data kommer formentlig slut 2024 og herefter har Janssen kort tid til at beslutte sig

                                  1 Reply Last reply
                                  0
                                  • R Offline
                                    R Offline
                                    Raun
                                    wrote on sidst redigeret af
                                    #758

                                    Tak @Sukkeralf.... Føj det bliver kursmæssigt et laaaangt 2024 😞

                                    1 Reply Last reply
                                    0
                                    • W Offline
                                      W Offline
                                      w
                                      wrote on sidst redigeret af
                                      #759

                                      Det er US inflation der styrer det her show

                                      1 Reply Last reply
                                      0
                                      • L Offline
                                        L Offline
                                        lahn1
                                        wrote on sidst redigeret af
                                        #760

                                        Den inflation slutter vel først når Biden holder op med at bruge penge og det bliver vel først efter valget.

                                        1 Reply Last reply
                                        0

                                        Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                        Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                        With your input, this post could be even better 💗

                                        Tilmeld Log ind
                                        Svar
                                        • Svar som emne
                                        Login for at svare
                                        • Ældste til nyeste
                                        • Nyeste til ældste
                                        • Most Votes


                                        • Log ind

                                        • Har du ikke en konto? Tilmeld

                                        • Login or register to search.
                                        Powered by NodeBB Contributors
                                        • First post
                                          Last post
                                        0
                                        • Kategorier
                                        • Seneste
                                        • Etiketter
                                        • Populære
                                        • Verden
                                        • Bruger
                                        • Grupper